Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

SYNAREL® Other (nafarelin acetate)

CENTRAL PRECOCIOUS PUBERTY (FOR ENDOMETRIOSIS, SEE REVERSE SIDE)

PHYSICIAN LABELING

Logo

LAB-1048-4.0
Revised: April 2022

Synarel®
(nafarelin acetate)
nasal solution

ENDOMETRIOSIS (FOR CENTRAL PRECOCIOUS PUBERTY, SEE REVERSE SIDE)

PHYSICIAN LABELING

Logo

LAB-0173-13.0
Revised: January 2023

Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event